Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

about

Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.

P2860

Q38892614-477A3840-2228-42DE-B670-253FFE539A86

P2860

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

Item

http://www.wikidata.org/entity/Q38522574

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

@en

type

Item

label

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

@en

prefLabel

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

@en

P1476

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

@en

P2093

Tamara Nawar

http://www.w3.org/2001/XMLSchema#string

Zeina A Kanafani

http://www.w3.org/2001/XMLSchema#string

P2860

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus

Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus

Risk factors for linezolid-associated thrombocytopenia in adult patients.

Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects.

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

Ceftaroline fosamil: drug profile and clinical data.

Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus.

Tissue penetration of telavancin after intravenous administration in healthy subjects.

Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.

P304

825-833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2015.1043889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26059192

http://www.w3.org/2001/XMLSchema#string

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

about

P2860

P2860

Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698